After revascularization for PAD, rivaroxaban reduced vascular events with a small increase in major bleeding.
Where this comes from
- Record sourced from PubMed, PMID 32805167.
- Also identified by DOI 10.7326/ACPJ202008180-022.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bonaca MP, Bauersachs RM, Anand SS, et al. <b>Rivaroxaban in peripheral artery disease after revascularization.</b> N Engl J Med. 2020;382:1994-2004. 32222135.
Medical subject headings
- Peripheral Arterial Disease
- Rivaroxaban